Tocilizumab is a humanized monoclonal antibody that targets the interleukin-6 receptor (IL-6-R). It is approved for use in moderate to severe refractory rheumatoid arthritis and more recently has been found to be effective in treating neuromyelitis optica.1 Common side effects include raised hepatic transaminases, gastroenteritis, infections, and hypertension. Neurologic side effects have been described in 2 single case reports, which were confounded by the concomitant use of other antirheumatic therapies and lengthy durations between tocilizumab administration and onset of neurologic symptoms.,3 We describe the clinico-histologic analysis of an acute neurologic deterioration 2 weeks after the first infusion of tocilizumab.

Tocilizumab-associated multifocal cerebral thrombotic microangiopathy / Jewell, Paul; Ansorge, Olaf; Kuker, Wilhelm; Irani, Sarosh R.; Zamboni, Giovanna. - In: NEUROLOGY. CLINICAL PRACTICE. - ISSN 2163-0402. - 6:(2016), pp. e24-e26. [10.1212/CPJ.0000000000000220]

Tocilizumab-associated multifocal cerebral thrombotic microangiopathy

ZAMBONI, Giovanna
2016

Abstract

Tocilizumab is a humanized monoclonal antibody that targets the interleukin-6 receptor (IL-6-R). It is approved for use in moderate to severe refractory rheumatoid arthritis and more recently has been found to be effective in treating neuromyelitis optica.1 Common side effects include raised hepatic transaminases, gastroenteritis, infections, and hypertension. Neurologic side effects have been described in 2 single case reports, which were confounded by the concomitant use of other antirheumatic therapies and lengthy durations between tocilizumab administration and onset of neurologic symptoms.,3 We describe the clinico-histologic analysis of an acute neurologic deterioration 2 weeks after the first infusion of tocilizumab.
2016
6
e24
e26
Tocilizumab-associated multifocal cerebral thrombotic microangiopathy / Jewell, Paul; Ansorge, Olaf; Kuker, Wilhelm; Irani, Sarosh R.; Zamboni, Giovanna. - In: NEUROLOGY. CLINICAL PRACTICE. - ISSN 2163-0402. - 6:(2016), pp. e24-e26. [10.1212/CPJ.0000000000000220]
Jewell, Paul; Ansorge, Olaf; Kuker, Wilhelm; Irani, Sarosh R.; Zamboni, Giovanna
File in questo prodotto:
File Dimensione Formato  
NEURCLINPRACT2015012963.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 304.44 kB
Formato Adobe PDF
304.44 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1108776
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 19
social impact